Cargando…
Effect of Metformin on Doxorubicin-Induced Memory Dysfunction
Doxorubicin (DOX) is widely used to treat many types of cancer; however, it is associated with chemotherapy-related complications such as cognitive dysfunction, known as chemobrain. Chemobrain affects up to 75% of cancer survivors, and there are currently no available therapeutic options. This study...
Autores principales: | Alharbi, Ibrahim, Alharbi, Hindi, Almogbel, Yasser, Alalwan, Abdullah, Alhowail, Ahmad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139300/ https://www.ncbi.nlm.nih.gov/pubmed/32156040 http://dx.doi.org/10.3390/brainsci10030152 |
Ejemplares similares
-
Research advances on how metformin improves memory impairment in “chemobrain”
por: Alhowail, Ahmad, et al.
Publicado: (2021) -
Metformin Improves the Depression Symptoms of Women with Polycystic Ovary Syndrome in a Lifestyle Modification Program
por: AlHussain, Fatimah, et al.
Publicado: (2020) -
Protective Effect of Galantamine against Doxorubicin-Induced Neurotoxicity
por: Alsikhan, Rawan S., et al.
Publicado: (2023) -
Evaluation of the health status outcome among inpatients treated for Amphetamine Addiction
por: Alharbi, Raed Saud, et al.
Publicado: (2022) -
Sukkari dates seed improves type-2 diabetes mellitus-induced memory impairment by reducing blood glucose levels and enhancing brain cholinergic transmission: In vivo and molecular modeling studies
por: Mani, Vasudevan, et al.
Publicado: (2022)